Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 3.96M | $13.1M | $3.31 | Nov 10, 2021 | Indirect |
Fulcrum Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 75.8K | $251K | $3.31 | Nov 10, 2021 | Direct |
Voyager Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15K | Jun 3, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FULC | Fulcrum Therapeutics, Inc. | Nov 10, 2021 | 1 | $0 | 4 | Nov 12, 2021 | Director, 10%+ Owner |
FULC | Fulcrum Therapeutics, Inc. | Sep 22, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Director, 10%+ Owner |
FULC | Fulcrum Therapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
VYGR | Voyager Therapeutics, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director, 10%+ Owner |